Masimo (MASI) Total Debt Growth (1y) (2015 - 2026)
Masimo (MASI) Total Debt Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 19.06% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -5.76% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -2.49% |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -28.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -28.93% |
| Jan 3, 2026 | -27.48% |
| Sep 27, 2025 | -27.63% |
| Jun 28, 2025 | -17.79% |
| Mar 29, 2025 | -24.41% |
| Dec 28, 2024 | -18.06% |
| Sep 28, 2024 | -17.76% |
| Jun 29, 2024 | -16.01% |
| Mar 30, 2024 | -6.25% |
| Dec 30, 2023 | -7.42% |
| Sep 30, 2023 | -1.26% |
| Jul 1, 2023 | -3.64% |
| Oct 1, 2016 | -19.81% |
| Jul 2, 2016 | -1.47% |
| Apr 2, 2016 | 79.79% |
| Jan 2, 2016 | 47.85% |
| Oct 3, 2015 | 51.86% |
| Jul 4, 2015 | 136.15% |
| Jan 3, 2015 | 37,169.05% |